This website contains medicines promotional information and is intended for UK & Ireland healthcare professionals only. A link to Prescribing Information and adverse event reporting information can be found at the bottom of this page.
This website has been produced in collaboration with international experts. Information may be based on expert opinion in addition to published references.

Guidance on the assessment of iMCD for pathologists

STEP 1:
Grading

To be diagnosed with iMCD a patient must have Grade 2–3 regressed germinal centres OR Grade 2–3 plasmacytosis. We recommend you begin by assessing these features, for which you can find guidance below. Information on typical constellations of histopathological features.

Features of which one must be present at Grade 2–3 for diagnosis

Additional features supportive of diagnosis and histopathological subtyping

In support of the grading guidance, our expert panel have provided real-world case studies and guidance on how they were graded for your reference.

Abbreviations

iMCD, idiopathic Multicentric Castleman Disease.

This tool has been funded and produced by Recordati Rare Diseases (RRD). All images have been provided by an international panel of expert pathologists.
The concept, functionality and expert guidance found within this tool has also been developed with the support of expert pathologists.